RSV fusion glycoprotein subunit vaccine (GlaxoSmithKline)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRSV fusion glycoprotein subunit vaccine (GlaxoSmithKline)
Drug Alias NameRSV F subunit vaccine (Novartis)RSV fusion glycoprotein subunit vaccine (Novartis)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionEnvelope glycoprotein modulators
TargetsEnvelope glycoprotein
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Vaccines And Diagnostics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Vaccines And Diagnostics IncGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A